New York, Aug 5 (IANS) Single-dose of a new monoclonal antibody (mAb) has shown to be safe and highly protective in adults exposed to the malaria parasite,
One injection of a candidate monoclonal antibody (mAb) known as L9LS was found to be safe and highly protective in U.S. adults exposed to the malaria parasite, according to results from a National Institutes of Health Phase 1 clinical trial.
L9LS antibody safe and highly protective against malaria, finds study europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.